VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
105 hedge funds and large institutions have $1.33B invested in Verona Pharma in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
65% less call options, than puts
Call options by funds: $3.32M | Put options by funds: $9.42M
Holders
105
Holding in Top 10
12
Calls
$3.32M
Puts
$9.42M
Top Buyers
| 1 | +$53.8M | |
| 2 | +$35.2M | |
| 3 | +$26.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.4M |
| 5 |
Jennison Associates
New York
|
+$7.6M |
Top Sellers
| 1 | -$58M | |
| 2 | -$26.3M | |
| 3 | -$11M | |
| 4 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$10.4M |
| 5 |
O
OrbiMed
New York
|
-$10.2M |